Evidence map›Paper›PMID 39919747›Full record

ArticleMolecular cell2025

Exposure of negative-sense viral RNA in the cytoplasm initiates innate immunity to West Nile virus.

Emmanuelle Genoyer, Jonathan Wilson, Joshua M Ames, Caleb Stokes, Dante Moreno, Noa Etzyon, Andrew Oberst, Michael Gale

Abstract read
In one paragraph

Article in Molecular cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Emmanuelle GenoyerDepartment of Immunology, University of Washington, Seattle, WA, USA.
Jonathan WilsonDepartment of Immunology, University of Washington, Seattle, WA, USA.
Joshua M AmesDepartment of Immunology, University of Washington, Seattle, WA, USA.
Caleb StokesDepartment of Immunology, University of Washington, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, WA, USA.
Dante MorenoDepartment of Immunology, University of Washington, Seattle, WA, USA.
Noa EtzyonDepartment of Immunology, University of Washington, Seattle, WA, USA.
Andrew OberstDepartment of Immunology, University of Washington, Seattle, WA, USA.
Michael GaleDepartment of Immunology, University of Washington, Seattle, WA, USA; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA, USA; Department of Microbiology and Immunology, University of Minnesota School of Medicine, Minneapolis, MN, USA; Institute on Infectious Diseases, University of Minnesota School of Medicine, Minneapolis, MN, USA. Electronic address: mgale@umn.edu.

Funding

Innate Immune Regulation of Zika Virus InfectionR01AI145296 · NIAID · UNIVERSITY OF WASHINGTON · PI COYNE, CAROLYN B, DIAMOND, MICHAEL S · 2019 to 2023
$4.1M
Innate Immune Control of West Nile VirusR01AI104002 · NIAID · UNIVERSITY OF WASHINGTON · PI DIAMOND, MICHAEL S, GALE, MICHAEL · 2013 to 2017
$3.7M
Innate Immunity to West Nile VirusR01AI179722 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale, Andrew Atwell Oberst · 2024 to 2026
$2.6M
Innate Immune Mechanisms Controlling Flavivirus NeurovirulenceR01AI183793 · NIAID · UNIVERSITY OF MINNESOTA · PI Michael Gale, Andrew Atwell Oberst · 2024 to 2026
$2.4M
Innate Immunity of Zika Virus Infection In Human Neural ProgenitorsK08AI150996 · NIAID · UNIVERSITY OF WASHINGTON · PI STOKES, CALEB · 2020 to 2024
$975k
Leica SP8 WWL Confocal MicroscopeS10OD016240 · OD · UNIVERSITY OF WASHINGTON · PI CATTERALL, WILLIAM A · 2014 to 2014
$581k
"Survivor" neurons drive persistent inflammation following West Nile virus infectionR21AI178512 · NIAID · UNIVERSITY OF WASHINGTON · PI OBERST, ANDREW ATWELL · 2023 to 2024
$485k
Identity and Accessibility of Immunostimulatory Viral RNAs During Flavivirus InfectionF32AI176736 · NIAID · UNIVERSITY OF WASHINGTON · PI GENOYER, EMMANUELLE · 2024 to 2025
$157k
NIAID NIH HHS F32 AI176736NIAID NIH HHS K08 AI150996NIAID NIH HHS R01 AI104002NIAID NIH HHS R01 AI145296NIAID NIH HHS R01 AI179722NIAID NIH HHS R01 AI183793NIAID NIH HHS R21 AI178512NIH HHS S10 OD016240
6 · The paper itself

Abstract

For many RNA viruses, immunity is triggered when RIG-I-like receptors (RLRs) detect viral RNA. However, only a minority of infected cells undergo innate immune activation. By examining these "first-responder" cells during West Nile virus infection, we found that specific accumulation of antigenomic negative-sense viral RNA (-vRNA) underlies innate immune activation and that RIG-I preferentially interacts with -vRNA. However, flaviviruses sequester -vRNA into membrane-bound replication compartments away from cytosolic sensors. We found that single-stranded -vRNA accumulates outside of replication compartments in first-responder cells, rendering it accessible to RLRs. Exposure of this -vRNA occurs at late time points of infection, is linked to viral assembly, and depends on the expression of viral structural proteins. These findings reveal that, although most infected cells replicate high levels of vRNA, release of -vRNA from replication compartments during assembly occurs at low frequency and is critical for initiation of innate immunity during flavivirus infection.

Indexed as

CytoplasmImmunity, InnateRNA, ViralWest Nile FeverWest Nile virusAnimalsDEAD Box Protein 58HEK293 CellsHost-Pathogen InteractionsHumansReceptors, ImmunologicVirus AssemblyVirus ReplicationDEAD Box Protein 58Receptors, ImmunologicRIGI protein, humanRNA, Viralantiviral responseinnate immunityRIG-IRIG-I-like receptorsWest Nile virus

Identifiers

PMID39919747
PMCPMC11931551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.